LakeShore Depreciation And Amortization vs Research Development Analysis

LSBPW Stock

0.04 0 3.90%

LakeShore Biopharma financial indicator trend analysis is infinitely more than just investigating LakeShore Biopharma Co, recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether LakeShore Biopharma Co, is a good investment. Please check the relationship between LakeShore Biopharma Depreciation And Amortization and its Research Development accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LakeShore Biopharma Co,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Depreciation And Amortization vs Research Development

Depreciation And Amortization vs Research Development Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of LakeShore Biopharma Co, Depreciation And Amortization account and Research Development. At this time, the significance of the direction appears to have almost identical trend.

The correlation between LakeShore Biopharma's Depreciation And Amortization and Research Development is 0.95. Overlapping area represents the amount of variation of Depreciation And Amortization that can explain the historical movement of Research Development in the same time period over historical financial statements of LakeShore Biopharma Co,, assuming nothing else is changed. The correlation between historical values of LakeShore Biopharma's Depreciation And Amortization and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Depreciation And Amortization of LakeShore Biopharma Co, are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Depreciation And Amortization i.e., LakeShore Biopharma's Depreciation And Amortization and Research Development go up and down completely randomly.

Correlation Coefficient

0.95

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

Research Development

Most indicators from LakeShore Biopharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into LakeShore Biopharma Co, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LakeShore Biopharma Co,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Sales General And Administrative To Revenue is likely to climb to 0.31 in 2024, despite the fact that Tax Provision is likely to grow to (20.6 M).

	2021	2022	2023	2024 (projected)
Interest Expense	2.7M	30.9M	44.3M	29.6M
Depreciation And Amortization	31.2M	36.7M	42.2M	37.9M

Interest Expense Depreciation And Amortization

LakeShore Biopharma fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Lease Obligations	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets
Total Assets		0.98	0.87	0.91	0.88	0.96	-0.13	0.96	-0.87	0.96	-0.73	0.96	-0.97	0.93	-0.73	0.96	0.5	-0.81	-0.89	0.95	-0.32	0.89	-0.69	0.94	0.96	0.96
Short Long Term Debt Total	0.98		0.84	0.92	0.8	0.99	-0.04	0.98	-0.85	0.94	-0.8	0.98	-1.0	0.93	-0.8	0.95	0.57	-0.74	-0.9	0.99	-0.28	0.84	-0.6	0.89	0.99	0.89
Other Current Liab	0.87	0.84		0.97	0.96	0.76	-0.46	0.87	-0.97	0.92	-0.77	0.77	-0.81	0.63	-0.77	0.95	0.82	-0.97	-0.98	0.89	-0.73	0.99	-0.89	0.97	0.86	0.9
Total Current Liabilities	0.91	0.92	0.97		0.91	0.85	-0.26	0.93	-0.94	0.95	-0.81	0.85	-0.89	0.73	-0.81	0.98	0.81	-0.89	-0.99	0.96	-0.62	0.94	-0.81	0.95	0.93	0.89
Total Stockholder Equity	0.88	0.8	0.96	0.91		0.72	-0.39	0.8	-0.9	0.94	-0.59	0.73	-0.76	0.64	-0.59	0.95	0.67	-0.99	-0.92	0.82	-0.71	0.99	-0.95	0.99	0.8	0.96
Property Plant And Equipment Net	0.96	0.99	0.76	0.85	0.72		-0.01	0.97	-0.8	0.87	-0.8	1.0	-1.0	0.97	-0.8	0.88	0.45	-0.65	-0.82	0.96	-0.13	0.76	-0.48	0.83	0.98	0.84
Current Deferred Revenue	-0.13	-0.04	-0.46	-0.26	-0.39	-0.01		-0.19	0.55	-0.12	0.4	-0.06	0.04	0.14	0.4	-0.19	-0.5	0.52	0.36	-0.14	0.62	-0.45	0.42	-0.33	-0.12	-0.2
Net Debt	0.96	0.98	0.87	0.93	0.8	0.97	-0.19		-0.9	0.9	-0.89	0.98	-0.99	0.9	-0.89	0.93	0.63	-0.76	-0.92	0.99	-0.31	0.85	-0.59	0.88	1.0	0.85
Retained Earnings	-0.87	-0.85	-0.97	-0.94	-0.9	-0.8	0.55	-0.9		-0.86	0.87	-0.82	0.83	-0.66	0.87	-0.91	-0.8	0.92	0.96	-0.9	0.64	-0.95	0.78	-0.93	-0.88	-0.85
Accounts Payable	0.96	0.94	0.92	0.95	0.94	0.87	-0.12	0.9	-0.86		-0.66	0.87	-0.9	0.81	-0.66	0.99	0.62	-0.89	-0.93	0.93	-0.52	0.94	-0.83	0.97	0.92	0.97
Cash	-0.73	-0.8	-0.77	-0.81	-0.59	-0.8	0.4	-0.89	0.87	-0.66		-0.82	0.82	-0.66	1.0	-0.72	-0.76	0.61	0.83	-0.87	0.33	-0.7	0.4	-0.68	-0.86	-0.58
Non Current Assets Total	0.96	0.98	0.77	0.85	0.73	1.0	-0.06	0.98	-0.82	0.87	-0.82		-0.99	0.97	-0.82	0.88	0.46	-0.66	-0.83	0.96	-0.14	0.77	-0.48	0.83	0.98	0.84
Non Currrent Assets Other	-0.97	-1.0	-0.81	-0.89	-0.76	-1.0	0.04	-0.99	0.83	-0.9	0.82	-0.99		-0.95	0.82	-0.91	-0.52	0.69	0.86	-0.98	0.2	-0.8	0.54	-0.86	-0.99	-0.86
Long Term Debt	0.93	0.93	0.63	0.73	0.64	0.97	0.14	0.9	-0.66	0.81	-0.66	0.97	-0.95		-0.66	0.81	0.24	-0.53	-0.68	0.87	0.05	0.66	-0.38	0.75	0.91	0.8
Cash And Short Term Investments	-0.73	-0.8	-0.77	-0.81	-0.59	-0.8	0.4	-0.89	0.87	-0.66	1.0	-0.82	0.82	-0.66		-0.72	-0.76	0.61	0.83	-0.87	0.33	-0.7	0.4	-0.68	-0.86	-0.58
Net Receivables	0.96	0.95	0.95	0.98	0.95	0.88	-0.19	0.93	-0.91	0.99	-0.72	0.88	-0.91	0.81	-0.72		0.68	-0.91	-0.96	0.95	-0.55	0.96	-0.83	0.98	0.94	0.97
Common Stock Shares Outstanding	0.5	0.57	0.82	0.81	0.67	0.45	-0.5	0.63	-0.8	0.62	-0.76	0.46	-0.52	0.24	-0.76	0.68		-0.75	-0.85	0.68	-0.81	0.73	-0.69	0.67	0.62	0.51
Non Current Liabilities Total	-0.81	-0.74	-0.97	-0.89	-0.99	-0.65	0.52	-0.76	0.92	-0.89	0.61	-0.66	0.69	-0.53	0.61	-0.91	-0.75		0.92	-0.78	0.8	-0.99	0.96	-0.96	-0.75	-0.9
Capital Lease Obligations	-0.89	-0.9	-0.98	-0.99	-0.92	-0.82	0.36	-0.92	0.96	-0.93	0.83	-0.83	0.86	-0.68	0.83	-0.96	-0.85	0.92		-0.94	0.66	-0.95	0.82	-0.95	-0.91	-0.87
Inventory	0.95	0.99	0.89	0.96	0.82	0.96	-0.14	0.99	-0.9	0.93	-0.87	0.96	-0.98	0.87	-0.87	0.95	0.68	-0.78	-0.94		-0.38	0.87	-0.64	0.9	1.0	0.87
Other Current Assets	-0.32	-0.28	-0.73	-0.62	-0.71	-0.13	0.62	-0.31	0.64	-0.52	0.33	-0.14	0.2	0.05	0.33	-0.55	-0.81	0.8	0.66	-0.38		-0.71	0.87	-0.62	-0.3	-0.5
Other Stockholder Equity	0.89	0.84	0.99	0.94	0.99	0.76	-0.45	0.85	-0.95	0.94	-0.7	0.77	-0.8	0.66	-0.7	0.96	0.73	-0.99	-0.95	0.87	-0.71		-0.91	0.99	0.84	0.95
Total Liab	-0.69	-0.6	-0.89	-0.81	-0.95	-0.48	0.42	-0.59	0.78	-0.83	0.4	-0.48	0.54	-0.38	0.4	-0.83	-0.69	0.96	0.82	-0.64	0.87	-0.91		-0.89	-0.59	-0.85
Net Invested Capital	0.94	0.89	0.97	0.95	0.99	0.83	-0.33	0.88	-0.93	0.97	-0.68	0.83	-0.86	0.75	-0.68	0.98	0.67	-0.96	-0.95	0.9	-0.62	0.99	-0.89		0.89	0.98
Property Plant And Equipment Gross	0.96	0.99	0.86	0.93	0.8	0.98	-0.12	1.0	-0.88	0.92	-0.86	0.98	-0.99	0.91	-0.86	0.94	0.62	-0.75	-0.91	1.0	-0.3	0.84	-0.59	0.89		0.87
Total Current Assets	0.96	0.89	0.9	0.89	0.96	0.84	-0.2	0.85	-0.85	0.97	-0.58	0.84	-0.86	0.8	-0.58	0.97	0.51	-0.9	-0.87	0.87	-0.5	0.95	-0.85	0.98	0.87

Click cells to compare fundamentals

LakeShore Biopharma Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for LakeShore Stock Analysis

When running LakeShore Biopharma's price analysis, check to measure LakeShore Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LakeShore Biopharma is operating at the current time. Most of LakeShore Biopharma's value examination focuses on studying past and present price action to predict the probability of LakeShore Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LakeShore Biopharma's price. Additionally, you may evaluate how the addition of LakeShore Biopharma to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

LakeShore Depreciation And Amortization vs Research Development Analysis

Depreciation And Amortization vs Research Development

Depreciation And Amortization vs Research Development Correlation Analysis

Correlation Coefficient

Depreciation And Amortization

Research Development

LakeShore Biopharma fundamental ratios Correlations

LakeShore Biopharma Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for LakeShore Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 1.0	Net Debt
Cash And Short Term Investments	+ 1.0	Cash
Property Plant And Equipment Gross	+ 1.0	Inventory
Property Plant And Equipment Net	+ 0.99	Short Long Term Debt Total
Inventory	+ 0.99	Short Long Term Debt Total

Non Currrent Assets Other	- 1.0	Property Plant And Equipment Net
Non Currrent Assets Other	- 1.0	Short Long Term Debt Total
Other Stockholder Equity	- 0.99	Non Current Liabilities Total
Property Plant And Equipment Gross	- 0.99	Non Currrent Assets Other
Non Currrent Assets Other	- 0.99	Non Current Assets Total
Non Currrent Assets Other	- 0.99	Net Debt